SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 5 — Sick Visit — Elvis Presley — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientElvis Presley
Date of birth1935-01-08
IdentifiersMRN HR-ML003-SYN-TD; SSN (made up) 000-03-4417
Document date1974-09-09
AuthorColeman Ashby-Nakagawa, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Low back pain for two days after karate practice. [S]

History of Present Illness

Mr. Presley asked for a same-day visit. Two days ago, a week after returning from his Las Vegas engagement, he twisted while practicing karate and felt a sharp pain across the left lower back. The pain is worse when he bends, stands up from a chair or turns in bed, and eases lying on his side with heat. It does not go down his legs. He has no numbness, weakness, bladder or bowel change, numbness in the saddle area, fever or chills, and no history of cancer or injected drugs. He rates the pain 7 out of 10. He has taken his usual buprenorphine 16 mg each morning, no other opioid and no extra diazepam, and he is worried that the pain will make him want his old pills and that it will not settle before the tour in eighteen days. The prescription drug monitoring program shows only this clinic's prescriptions. [S]

ElementDetail
OnsetTwo days ago, twisting during karate practice
LocationLeft lower back, without radiation
DurationTwo days
CharacterSharp, with spasm
Severity7 of 10
TimingWorse with bending, rising and turning
ContextBuprenorphine 16 mg daily; tour in eighteen days
Modifying factorsBetter lying on his side with heat
Associated signs and symptomsNo leg pain, numbness, weakness, bladder or bowel change, or fever

Review of Systems

SystemResultFinding
MusculoskeletalPositiveLeft lower back pain and spasm
NeurologicalNegativeNo leg weakness, numbness or saddle anesthesia
GenitourinaryNegativeNo retention or incontinence
ConstitutionalNegativeNo fever, chills or unintended weight loss
PsychiatricNegativeWorried about cravings; no thoughts of suicide or self-harm

5 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Hydromorphone 4 mg oral tablet, prescribed elsewhere as one tablet every four to six hours as needed for back and neck pain; taking about five a day (20 mg, 100 MME); continued by this clinic only, at the verified dose and seven days at a time, until the addiction medicine consultationUp to five tablets a day; seven-day supplyOral route1974-07-10 to 1974-07-17completedS
Oxycodone 10 mg and acetaminophen 325 mg oral tablet, prescribed by a second prescriber; taking about three a day (45 MME); continued by this clinic only, seven days at a time, until the consultationUp to three tablets a day; seven-day supplyOral route1974-07-10 to 1974-07-17completedS
Diazepam 10 mg oral tablet, one tablet three times daily, prescribed elsewhere for anxiety; continued by this clinic only, seven days at a timeOne tablet three times daily; seven-day supplyOral route1974-07-10 to 1974-07-17completedS
Alprazolam 1 mg oral tablet, up to three a day as needed, prescribed by a fourth prescriber while on tour; continued by this clinic only, at the verified dose, seven days at a timeUp to three tablets a day; seven-day supplyOral route1974-07-10 to 1974-07-17completedS
Phentermine 37.5 mg oral tablet each morning, prescribed by a weight clinic; stopped today because of high blood pressure and his glaucomaStoppedOral route1974-07-10 to 1974-07-10completedS
Latanoprost 0.005% eye drops, one drop in each eye at bedtime, prescribed by his ophthalmologistOne drop in each eye at bedtimeOphthalmic route1974-07-10activeS
Naloxone 4 mg nasal spray, one spray into one nostril for a suspected overdose, repeated in the other nostril after two to three minutes if needed; two-pack, with a second for the tour bagOne spray for a suspected overdose; call 911Nasal route1974-07-10activeS
Polyethylene glycol 3350, 17 g powder in a glass of water once daily17 g in water once dailyOral route1974-07-10activeS
Senna 8.6 mg oral tablet, two tablets at bedtimeTwo tablets at bedtimeOral route1974-07-10 to 1974-08-07completedS
Buprenorphine 8 mg and naloxone 2 mg sublingual film, two films (16 mg) under the tongue once daily, which may be split into one film twice daily; started in the office at the consultation; seven-day supplies at first, from this clinic onlyTwo films once daily, or one film twice dailySublingual route1974-07-17activeS
Diazepam 10 mg oral tablet, one tablet four times daily (40 mg a day), replacing both diazepam 10 mg three times daily and alprazolam; held steady until buprenorphine is stableOne tablet four times daily; seven-day supplyOral route1974-07-17 to 1974-08-07completedS
Diazepam 10 mg oral tablet, one tablet three times daily, with diazepam 2 mg tablets for the taper steps; dispensed two weeks at a timeOne tablet three times daily with the 2 mg tablets as scheduledOral route1974-08-07activeS
Diazepam 2 mg oral tablet on the written taper schedule: three a day (36 mg a day in all) from the three-week visit, one a day (32 mg) from the ten-week visit, stopped at four months (30 mg)Per the written taper scheduleOral route1974-08-07 to 1974-10-28completedS
Amlodipine 5 mg and valsartan 160 mg oral tablet, one tablet dailyOne tablet dailyOral route1974-07-17activeS
Tirzepatide 2.5 mg/0.5 mL auto-injector, 2.5 mg under the skin once weekly2.5 mg once weeklySubcutaneous route1974-08-07 to 1974-09-23completedS
Naproxen 500 mg oral tablet, one tablet twice daily with food for five daysOne tablet twice daily with food for five daysOral route1974-09-09 to 1974-09-13completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1974-09-09Body height183cmS
1974-09-09Body weight106kgS
1974-09-09Body mass index (BMI) [Ratio]31.7kg/m2S
1974-09-09Systolic blood pressure134mm[Hg]S
1974-09-09Diastolic blood pressure84mm[Hg]S
1974-09-09Heart rate84/minS
1974-09-09Respiratory rate16/minS
1974-09-09Body temperature36.7CelS
1974-09-09Oxygen saturation in Arterial blood by Pulse oximetry97%S

Physical Exam

Vital signs recorded on 1974-09-09; see the Vital Signs section. [S]

SystemFinding
GeneralUncomfortable when moving; blood pressure 134/84, pulse 84, temperature 36.7 °C
BackTender spasm of the left lumbar paraspinal muscles; no midline tenderness; flexion limited by pain
NeurologicalStraight-leg raise negative both sides; strength, reflexes and sensation normal in the legs; normal gait
AbdomenSoft, non-tender

Problems

ProblemClinical statusVerificationCodeProvenance
Fatigue, weight gain of about 14 kg in two years, constipation with a bowel movement every five to seven days, loud snoring with daytime sleepiness, and high blood pressure readings, in a man taking two opioids, two benzodiazepines and an appetite suppressant from five prescribers; under evaluation with addiction medicine, a sleep study and home blood pressure readingsresolvedconfirmed R53.83S — Synthetic presenting problem anchored to the documented prescribed drugs and weight gain; superseded when the consultation and tests made the diagnoses.
Obesity, class 1 (BMI 32.5), with prediabetes (hemoglobin A1c 5.8%); recorded without stigma; weight gain began with long touring schedules, night eating after shows and an appetite suppressant that stopped workingactiveconfirmed E66.811S — Synthetic modern diagnosis anchored to his documented weight gain.
Glaucoma secondary to steroids, both eyes, mild stage, after an acute angle-closure episode treated years ago; intraocular pressure controlled on latanoprost under his ophthalmologist; anticholinergic and sympathomimetic drugs to be avoidedactiveconfirmed H40.63X1S — Synthetic modern diagnosis anchored to his documented glaucoma and the retrospective interpretation of it as steroid-induced; not a claim about his real eyes.
Opioid use disorder, severe, with prescription opioids from more than one prescriber (seven DSM-5-TR criteria, tolerance and withdrawal counted because the opioids were not taken as prescribed); on buprenorphine from the consultation; synthetic modern episode linked to his documented withdrawal from narcotic drugs and prescribed painkillersactiveconfirmed F11.20S — Synthetic modern diagnosis made at the addiction medicine consultation; person-first language; not a claim about his real diagnosis.
Sedative, hypnotic, or anxiolytic use disorder (benzodiazepines), moderate (five DSM-5-TR criteria), with two benzodiazepines from two prescribers; combined into diazepam and tapering slowly; synthetic modern episode linked to his documented prescribed sedativesactiveconfirmed F13.20S — Synthetic modern diagnosis made at the consultation; not a claim about his real diagnosis.
Hypertension, stage 2, confirmed by a home average of 146/94 a week after stopping phentermine; ECG and urine albumin normalactiveconfirmed I10S — Synthetic modern diagnosis confirmed with home readings, anchored to his documented hypertension.
Obstructive sleep apnea, moderate (apnea-hypopnea index 26 an hour, central apnea index 4, oxygen nadir 80% on in-laboratory polysomnography), worsened by opioids and benzodiazepines; on CPAPactiveconfirmed G47.33S — Synthetic modern diagnosis from a synthetic sleep study.
Opioid-induced constipation (Rome IV), improving after the change to buprenorphine; no alarm featuresactiveconfirmed K59.03S — Synthetic modern diagnosis anchored to his documented blockage of the colon; not a claim about megacolon.
Acute low back strain after karate practice, without radicular signs or red flags, in a man on buprenorphine; resolvedactiveconfirmed S39.012AS — Synthetic acute injury; not a historical claim.

Assessment and Plan

Guideline basis: CDC Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022 (2022); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020); Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians (2017)

Follow-up: Phone check in three days. Ten-week review in two weeks, before the tour. Return sooner as above. Next scheduled visit 1974-09-23: ten-week review after the Las Vegas engagement and a back strain: buprenorphine, the taper, weight treatment, sleep apnea and planning for a three-week tour. [S]